SurgePays (SURG) Misses Q3 EPS by 46c

SurgePays (NASDAQ: SURG) reported Q3 EPS of ($0.73), $0.46 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $4.77 million versus the consensus estimate of $5.88 million.

For earnings history and earnings-related data on SurgePays (SURG) click here.

You May Also Be Interested In

• Evercore ISI Reiterates Underperform Rating on Lennar (LEN)
• Legend Biotech reports early clinical trial results for LB2501 therapy
• Celldex reports sustained angioedema improvements 7 months post-treatment